Amanote Research

Amanote Research

    RegisterSign In

A Generic RNA Pulsed DC Based Approach for Developing Therapeutic Intervention Against Nasopharyngeal Carcinoma

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2016.1256518
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineAllergyImmunologyPharmacology
Date

November 30, 2016

Authors
Rajeev K. TyagiRajesh ParmarNaisargee Patel
Publisher

Informa UK Limited


Related search

Developing a Prognostic Micro-Rna Signature for Human Cervical Carcinoma

PLoS ONE
Multidisciplinary
2015English

Developing a Digital Intervention for Cancer Survivors: An Evidence-, Theory- And Person-Based Approach

npj Digital Medicine
2019English

Omics-Based Identification of Biomarkers for Nasopharyngeal Carcinoma

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2015English

Interleukin 35 Is an Independent Prognostic Factor and a Therapeutic Target for Nasopharyngeal Carcinoma

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2015English

DC-based Vacccine for Intrahepatic Cholangiocellular Carcinoma

Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
2012English

MRI-based Radiomics Signature Is a Quantitative Prognostic Biomarker for Nasopharyngeal Carcinoma

Scientific Reports
Multidisciplinary
2019English

Therapeutic Implications of Epstein–Barr Virus Infection for the Treatment of Nasopharyngeal Carcinoma

Therapeutics and Clinical Risk Management
2014English

Nasopharyngeal Carcinoma

2019English

Nasopharyngeal Carcinoma

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy